Prof. Peter Bauer, Rare Disease Expert
Prof. Peter Bauer, M.D., is passionate about turning medical questions into complete and fast analytical processes – ensuring that medically-driven results are brought to clinicians and patients immediately. He received his board certification in Human Genetics in 2006 and previously headed the Molecular Diagnostic Laboratory at the Institute of Medical Genetics and Applied Genomics at the University Hospital Tübingen. Peter has authored more than 250 publications in Neurogenetics, Oncogenetics, Cardiogenetics, and Sequencing Technology. He currently serves as CENTOGENE's Chief Medical & Genomic Officer.

Dr. Katrin Hahn, Guest
Dr. Katrin Hahn is a renowned Neurologist and Senior Physician at Charité - Berlin University of Medicine – specializing in rare diseases, particularly amyloidosis, as well as polyneuropathy. With unparalleled expertise in these fields, Dr. Hahn serves as the Head of the Hereditary Neuropathies and Amyloidosis Research Group and the Neuro-AIDS Research Group at Charité. She is a member of several prestigious societies, including the International Federation of Clinical Neurophysiology and International Society of Amyloidosis, and her passion for research has led her to be published in several top tier journals – unlocking novel insights into a range of diseases, with an increased focus on hereditary transthyretin amyloidosis, otherwise known as ATTR.

Ben Legg, Host
Ben has been involved in the rare disease community for a number of years – with both Ehlers-Danlos syndrome and genetic Parkinson’s disease present in his family. In his personal life, he has also been involved with young cystic fibrosis and osteosarcoma patients going through diagnosis and treatment. Ben leads the Communications team at CENTOGENE, where he is grateful to have an opportunity to work together on a mission to find effective, data-driven solutions for life-changing answers for rare and neurodegenerative disease patients around the world.